NSE filing, NSE: REMUS. Summary written from the filing by ALFA Finder's alert engine.
Remus Pharmaceuticals Ltd: key numbers
- Share price
- ₹843.35
- Market cap
- ₹993.8 Cr
- Revenue (annual)
- ₹853.6 Cr
- Net profit (annual)
- ₹36.99 Cr
- P/E (TTM)
- 26.9×Sector 45.9×
- Promoter holding
- 70.95%
- FII holding
- 5.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Remus Pharmaceuticals Ltd
All →Remus Pharmaceuticals Other Announcement
Remus Pharmaceuticals filed its Reg 76 Reconciliation of Share Capital Audit Report for Q1 FY2027. It is a routine depository-compliance certificate with no transaction or business event.
Remus Pharmaceuticals Annual General Meeting
Remus Pharmaceuticals Limited shareholders approved the migration of equity shares from the NSE Emerge platform to the main boards of NSE and BSE.
Remus Pharmaceuticals Annual General Meeting
Remus Pharmaceuticals held its 11th Annual General Meeting on September 29, 2026. Shareholders discussed financial results, dividend declaration, and director appointments.
Remus Pharmaceuticals Dividend
Remus Pharmaceuticals Limited has fixed September 22, 2026, as the record date for determining shareholder entitlement to a final dividend of Rs. 0.50 per share.
Remus Pharmaceuticals Annual General Meeting
Remus Pharmaceuticals Limited has issued a postal ballot notice seeking shareholder approval for the migration of its equity shares from the NSE Emerge platform to Main Board.
Remus Pharmaceuticals Merger & Restructuring
Remus Pharmaceuticals will incorporate a new subsidiary in the Dominican Republic for pharmaceutical distribution. The company will hold at least 51% of its share capital.
Other other announcement announcements
All →Innomet Advanced Materials Other Announcement
Innomet Advanced Materials filed its half-year Reg 32 statement on preferential issue proceeds, with no deviation. Rs.753.25 lakh raised in August 2026 was fully used for working capital.
CCME Global Other Announcement
CCME Global disclosed insider trades by two connected persons, acquiring 90 lakh and 22.5 lakh shares on 28 October 2026. Combined consideration is stated as Rs.112.50 Crore.
- Value
- ₹112.5 Cr
Jay Jalaram Technologies Other Announcement
Jay Jalaram Technologies named its KMP as authorised persons for materiality determination under Regulation 30. This administrative listing carries no financial or business impact.
SPR Auto Technologies Other Announcement
SPR Auto Technologies filed its quarterly QIP monitoring agency report for the quarter ended September 30, 2026. The report found no deviation from the issue objects.
Vahh Chemicals Other Announcement
Vahh Chemicals filed its shareholding pattern for the quarter ended September 30, 2026. Promoters and promoter group hold about 64.63% of total shares.
Maharaja & Speedex India Other Announcement
Maharaja & Speedex India filed its quarterly shareholding pattern as of 18 September 2026 under Regulation 31. It shows promoter and public holdings with no transaction or capital event.